Tilray Inc TLRY is trading higher Wednesday morning amid increased retail interest following the launch of a new medical cannabis brand.
What Happened: Tilray on Tuesday announced Symbios, a new medical cannabis brand it launched in order to provide a broader spectrum of formats and unique cannabinoid ratios at a better price point.
Symbios offers medical patients health and wellness products including flower, oils and pre-rolls.
“As we look ahead, we remain focused on building momentum across our three medical brands – Symbios, Aphria, and Tilray -- while meeting the large and growing demand for new, high-quality cannabis products that promote health, wellness, and wellbeing," said Irwin D. Simon, CEO of Tilray.
See Also: Is Tilray The Next Short Squeeze Candidate?
Retail Interest: Tilray is the top mentioned cannabis stock on the Subreddit r/wallstreetbets over the last 24 hours. The stock is also in the top ten most-mentioned stocks of all tickers on the popular Subreddit.
Price Action: Tilray has traded as high as $67 and as low as $4.41 over a 52-week period.
At last check Wednesday, the stock was up 8.85% at $22.01.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!